APA (7th ed.) Citation

van Thor, M. C. J., ten Klooster, L., Snijder, R. J., Kelder, J. C., Mager, J. J., & Post, M. C. (2019). Bosentan or Macitentan Therapy in Chronic Thromboembolic Pulmonary Hypertension? Lung (0341-2040), 197(6), 753. https://doi.org/10.1007/s00408-019-00274-9

Chicago Style (17th ed.) Citation

van Thor, M. C. J., L. ten Klooster, R. J. Snijder, J. C. Kelder, J. J. Mager, and M. C. Post. "Bosentan or Macitentan Therapy in Chronic Thromboembolic Pulmonary Hypertension?" Lung (0341-2040) 197, no. 6 (2019): 753. https://doi.org/10.1007/s00408-019-00274-9.

MLA (9th ed.) Citation

van Thor, M. C. J., et al. "Bosentan or Macitentan Therapy in Chronic Thromboembolic Pulmonary Hypertension?" Lung (0341-2040), vol. 197, no. 6, 2019, p. 753, https://doi.org/10.1007/s00408-019-00274-9.